THE

DOSE

Daily news for smarter treatment decisions.

Latest Stories

Editorial cartoon: trending up arrow on teal/yellow waves

Novo's Wegovy Pill Surge Forces Wall Street to Rethink Eli Lilly's Dominance

Novo Nordisk's Wegovy pill launch has doubled telehealth provider business overnight and reached tens of thousands of new patients, challenging expectations about Eli Lilly's GLP-1 market leadership.

RC Nelson·May 9, 2026

Novo Nordisk Launches Ozempic Pill in US with $149 Starting Price

By RC Nelson

Lilly's Foundayo Sees Modest Launch with Just 1,390 Prescriptions in Debut Week

By The Dose

Semaglutide Patent Expires in India, Triggering Generic GLP-1 Price War

By The Dose

The Dose

Three States Expand Telehealth Prescribing Rules for Weight Loss Medications

By RC Nelson·Mar 16, 2026

The Dose

Novo Nordisk Breaks Ground on $4.1 Billion Manufacturing Facility in North Carolina

By RC Nelson·Mar 11, 2026

The Dose

Medicare GLP-1 Coverage Bill Gains Bipartisan Support in Senate

By RC Nelson·Mar 5, 2026

Showing 3 of 7 articles.